Clinical Trial Update: Study of rhASB in Patients With Mucopolysaccharidosis VI [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of recombinant human arylsulfatase B (rhASB) in patients with mucopolysaccharidosis type VI completed, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Vi

Drugs mentioned

• rhASB (recombinant human arylsulfatase B)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Mucopolysaccharidosis VI | Phase 3 | Status: COMPLETED | Results posted: 2009-03-06